13G Filing: Sabby Capital and Heat Biologics Inc. (HTBX)

Page 4 of 9 – SEC Filing

OO
CUSIP No.
42237K 1021.
NAME OF REPORTING PERSONSHal Mintz2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONUSANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 2,615,1237.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 2,615,1239.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,615,12310.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)6.2912.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

IN?

CUSIP No.
42237K 102

Item 1.
(a).
Name of Issuer:Heat Biologics, Inc.

(b).
Address of issuer’s principal executive offices:100 EUropa Drive, Suite 420, Chapel Hill, NC 27517

Item 2.
(a).
Name of person filing:Sabby Healthcare Master Fund, Ltd.
Sabby Volatility Warrant Master Fund, Ltd.
Sabby Management, LLC
Hal Mintz